P1‐046: New Exploratory Alzheimer'S Drug Anavex 2‐73: Dose Dependent Clinical Cognitive Improvement Observed in Mini Mental State Examination (MMSE) and Other Cognitive Markers in a Phase 2A Study in Mild‐to‐Moderate Alzheimer's Patients. (1st July 2016) - Macfarlane, Stephen; Maruff, Paul; Cecchi, Marco; Moore, Dennis; Zografidis, Tasos; Missling, Christopher